Opiant Pharmaceuticals, Inc.
OPNTDelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385508
Opiant Pharmaceuticals, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 37 institutions reported holding it in 13F filings for Q4 2022, worth $43.2M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Opiant Pharmaceuticals, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- −1 vs. Q4 2021
- Shares held
- 1.56M
- +140.6K (+9.9%) vs. Q4 2021
- Total value
- $33.3M
- −$14.3M (−30.0%) vs. Q4 2021
- New holders
- 9
- 12 more added
- Sold out
- 10
- 13 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OPNT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 37 | $43.2M |
| Q3 2022 | 32 | $19.4M |
| Q2 2022 | 33 | $22.3M |
| Q1 2022 | 41 | $33.3M |
| Q4 2021 | 42 | $47.6M |
| Q3 2021 | 35 | $32.7M |
| Q2 2021 | 26 | $11.8M |
| Q1 2021 | 31 | $9.70M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Opiant Pharmaceuticals, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sage Private Wealth Group, LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 10 | $0 | 0.00% | +10 | New |
| National Bank of Canada | 100 | $2.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 154 | $3.00K | 0.00% | +154 | New |
| Federation des caisses Desjardins du Quebec | 180 | $3.86K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 252 | $5.00K | 0.00% | 00.0% | Unchanged |
| American Research & Management Co. | 300 | $6.00K | 0.00% | 00.0% | Unchanged |
| Lindbrook Capital, LLC | 500 | $11.0K | 0.00% | 00.0% | Unchanged |
| Spire Wealth Management | 500 | $11.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,022 | $22.0K | 0.00% | +717+235.1% | Added |
| Royal Bank of Canada | 1,400 | $30.0K | 0.00% | +200+16.7% | Added |
| Newbridge Financial Services Group, Inc. | 2,050 | $44.0K | 0.02% | +200+10.8% | Added |
| Advisor Group Holdings, Inc. | 5,425 | $116.0K | 0.00% | −2,700−33.2% | Reduced |
| JPMorgan Chase & Co | 7,466 | $160.0K | 0.00% | +723+10.7% | Added |
| Bridgeway Capital Management, LLC | 10,100 | $216.0K | 0.00% | −300−2.9% | Reduced |
| Millennium Management LLC | 11,577 | $248.0K | 0.00% | +11,577 | New |
| Trexquant Investment LP | 12,013 | $257.0K | 0.01% | +12,013 | New |
| State Street Corp | 13,285 | $285.0K | 0.00% | +1,285+10.7% | Added |
| Mariner, LLC | 13,550 | $290.0K | 0.00% | +13,550 | New |
| Marshall Wace, LLP | 13,584 | $291.0K | 0.00% | −9,993−42.4% | Reduced |
| Bailard, Inc. | 15,042 | $322.0K | 0.01% | −1,200−7.4% | Reduced |
| SG3 Management, LLC | 16,084 | $345.0K | 0.10% | +16,084 | New |
| D. E. Shaw & Co., Inc. | 16,989 | $364.0K | 0.00% | +16,989 | New |
| HealthInvest Partners AB | 18,000 | $386.0K | 0.61% | +18,000 | New |
| DLD Asset Management, LP | 20,000 | $428.0K | 0.03% | −10,000−33.3% | Reduced |
| Morgan Stanley | 26,675 | $571.0K | 0.00% | −7,661−22.3% | Reduced |
| Perritt Capital Management Inc | 30,500 | $653.0K | 0.35% | −1,500−4.7% | Reduced |
| Essex Investment Management Co LLC | 32,040 | $686.0K | 0.09% | +777+2.5% | Added |
| Parkman Healthcare Partners LLC | 32,557 | $697.0K | 0.20% | +1,266+4.0% | Added |
| BlackRock Inc. | 35,323 | $756.0K | 0.00% | +579+1.7% | Added |
| Northern Trust Corp | 37,078 | $794.0K | 0.00% | −772−2.0% | Reduced |
| Two Sigma Investments, LP | 38,832 | $832.0K | 0.00% | −25,225−39.4% | Reduced |
| Geode Capital Management, LLC | 47,998 | $1.03M | 0.00% | −2,246−4.5% | Reduced |
| Two Sigma Advisers, LP | 72,700 | $1.56M | 0.00% | −9,700−11.8% | Reduced |
| Dimensional Fund Advisors LP | 106,682 | $2.29M | 0.00% | +40,031+60.1% | Added |
| Apis Capital Advisors, LLC | 112,000 | $2.40M | 2.90% | +2,000+1.8% | Added |
| Acadian Asset Management LLC | 116,478 | $2.49M | 0.01% | +44,562+62.0% | Added |
| Ovata Capital Management Ltd | 117,865 | $2.52M | 0.78% | +117,865 | New |
| Renaissance Technologies LLC | 178,015 | $3.81M | 0.00% | −5,800−3.2% | Reduced |
| Vanguard Group Inc | 187,158 | $4.01M | 0.00% | +8,699+4.9% | Added |
| Wells Fargo & Company | 205,226 | $4.40M | 0.00% | −19,071−8.5% | Reduced |
| EAM Investors, LLC | 0 | $0 | 0.00% | −44,771−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −7,803−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −6,417−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −5,180−100.0% | Sold out |
| Hillsdale Investment Management Inc. | 0 | $0 | 0.00% | −3,200−100.0% | Sold out |
| Dorsey Wright & Associates | 0 | $0 | 0.00% | −2,138−100.0% | Sold out |
| TAP Consulting, LLC | 0 | $0 | 0.00% | −471−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −266−100.0% | Sold out |
| Retirement Planning Co of New England, Inc. | 0 | $0 | 0.00% | −180−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −63−100.0% | Sold out |